Data as of Apr 17
| -0.07 / -1.73%|
The 6 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 14.50, with a high estimate of 27.00 and a low estimate of 1.00. The median estimate represents a +266.16% increase from the last price of 3.96.
The current consensus among 7 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.